A commonly prescribed pain medication—gabapentin—often considered a safer alternative to opioids for those who suffer from low back pain is now under scrutiny after being linked to increased risks of ...

Thanks to a big settlement back in 2004 over off-label marketing epilepsy drug Neurontin, there's a new source of information about prescription drugs that isn't funded directly by Big Pharma. Run ...

Pfizer Inc has agreed to pay $325 million to resolve claims it defrauded insurers and other healthcare benefit providers by marketing Neurontin for unapproved uses, its second settlement over the ...